imvaria, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
imvaria, Inc. - overview
Established
2019
Location
Berkeley, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2019 by a team of physician-engineers from Stanford and Google, Joshua Reicher and Michael Muelly. Imvaria, Inc. operates as a developer of digital biomarkers. In January 2026, imvaria, Inc.
raised an undisclosed amount of venture funding from InHealth Ventures, Cedar Crest Holdings, Labcorp Venture, and National Institutes of Health. The company's novel Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning algorithm. The company will use the January 2026 funding to extend its AI-driven diagnostic services for lung diseases and increase clinician access to its tests.
Current Investors
Cloudstone Venture, Creative Ventures, InHealth Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Biopharmaceuticals, Diagnostic Equipment, Therapeutic Devices, Medical Software
Website
www.imvaria.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
imvaria, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.